Figure 4.
Five-year disease-specific survival in each pStage stratified by CD8+ TILs and color coded into distinct subgroups with similar survival and disease-specific survival curves according to pStage and to a proposed TNM-Immune cell score for all patients (A–C), the LUSC subgroup (D–F) and the LUAD subgroup (G–I).
